Anti-IL-13 Antibody (M1295) is a potent neutralizing antibody targeting human interleukin-13 (IL-13), acting by blocking the binding of IL-13 to its receptor complex. The compound is an essential tool for investigating Type 2 immune responses and the pathogenesis of bronchial asthma and atopic dermatitis, aiming to inhibit allergic inflammatory processes by downregulating IL-13-mediated signaling cascades.
Target:
IL Receptor
T9901A-1296
* VAT and and shipping costs not included. Errors and price changes excepted
